Skip to main content
. 2020 May 3;11(3):155–167. doi: 10.14740/cr1011

Table 3. Baseline Demographic and Clinical Characteristics of Non-RV Pacing-Dependent and Pacing-Dependent Patients at 1 Month Post-PPM Implant.

Non-RV pacing-dependent (n = 17) RV pacing-dependent (n = 8) P-value
Age 80.4 ± 6.3 80.9 ± 8.3 0.88
Gender (female) 8/17 2/8 0.40
BMI 29.1 ± 6.3 25.0 ± 4 .5 0.12
Hypertension 15/17 5/8 0.28
DM 10/17 2/8 0.2
CAD 14/17 5/8 0.34
CHF 13/17 5/8 0.64
COPD 2/17 1/8 1
PVD 4/17 1/8 0.64
History of atrial fibrillation 6/17 2/8 0.68
History of atrial flutter 1/17 1/8 1
eGFR < 60 10/17 7/8 0.21
Creatinine 1.36 ± 0.61 1.92 ± 1.42 0.19
Prior CABG 7/17 2/8 0.66
Prior PCI 3/17 3/8 0.34
Prior balloon valvuloplasty 5/17 0/8 0.14
ACE-I/ARB 7/17 5/8 0.41
Beta-blockers 10/17 6/8 0.66
Digoxin 0/17 0/8 1
Other anti-arrhythmic drugs 0/17 0/8 1

The P-values shown are derived from two-tailed Fisher’s exact test for categorical variables and two-tailed unpaired Student’s t-test for continuous variables. Patients who were non-RV pacing-dependent at 30 days and patients who were RV pacing-dependent at 30 days patients were separately compared with the non-pacemaker population to derive these P-values. Continuous variables are reported as the mean plus or minus the standard deviation. RV: right ventricular; PPM: permanent pacemaker; BMI: body mass index; DM: diabetes mellitus; CAD: coronary artery disease; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; PVD: peripheral vascular disease; eGFR: estimated glomerular filtration rate; CABG: coronary artery bypass grafting; PCI: percutaneous coronary intervention; ACE-I/ARB: angiotensin converting enzyme inhibitor/angiotensin receptor blocker.